Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR‐605/FOXO3/ABCB1 axis

Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma

(2020) Xia Liao et al.   BMC CANCER

Circular RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in Ovarian Cancer via miR-1270 suppression

(2019) Zhao Zhao et al.   Molecular Therapy-Nucleic Acids

Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop

(2019) Wei Zhao et al.   CELL DEATH AND DIFFERENTIATION

circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer

(2019) Yiran Liang et al.   ONCOGENE

High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma

(2019) Yilan Ma et al.   Frontiers in Oncology

The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma

(2019) Ling Wei et al.   Molecular Cancer

Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p

(2019) Yu Dong et al.   LIFE SCIENCES

Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma

(2018) Jing Meng et al.   CANCER RESEARCH

Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models

(2018) Janneke F. Linnekamp et al.   CELL DEATH AND DIFFERENTIATION

Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711

(2018) Nyree Crawford et al.   CELL DEATH AND DIFFERENTIATION

Gastric metastasis of recurrent hepatocellular carcinoma: A case report and literature review

(2018) Weidong Xiao et al.   Journal of Cancer Research and Therapeutics

Treatment strategy for huge hepatocellular carcinoma with intrahepatic metastasis and macrovascular invasion: a case report and literature review

(2018) Jie Wang et al.   Journal of Cancer Research and Therapeutics

LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363

(2018) Hai Huang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Hepatocellular carcinoma

(2018) Alejandro Forner et al.   LANCET

RNA Structure Design Improves Activity and Specificity of trans -Splicing-Triggered Cell Death in a Suicide Gene Therapy Approach

(2018) Sushmita Poddar et al.   Molecular Therapy-Nucleic Acids

A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumour Activity of Sorafenib in Hepatocelluar Carcinoma In Vitro and In Vivo

(2018) Kai Zhang et al.   Molecular Therapy-Nucleic Acids

Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes

(2018) Yajun Chen et al.   CELL DEATH AND DIFFERENTIATION

CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression

(2018) Hongjian Wang et al.   Molecular Cancer

Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma

(2018) Fang Huang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature

(2018) Jian-Chun Lu et al.   World Journal of Clinical Cases